CAT vs DMAC · P/E 48, rev $20.54B vs $157.4M cap
Caterpillar Inc (CAT) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
DMAC does not have a complete income-statement cache yet.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CAT and DMAC stock pages for the full models.
Not investment advice.